Journal of Vascular Surgery
Volume 47, Issue 3 , Pages 608-615 , March 2008

Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts

Presented at the Thirty-second Annual Meeting of the New England Society for Vascular Surgery, Stowe, Vt, Sept 17, 2005.

  • Geoffrey Wong, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School and the UMass Memorial Health Care, Worcester, Mass
  • ,
  • Jian-ming Li, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School and the UMass Memorial Health Care, Worcester, Mass
  • ,
  • Gregory Hendricks, PhD

      Affiliations

    • Department of Cell Biology, University of Massachusetts Medical School and the UMass Memorial Health Care, Worcester, Mass.
  • ,
  • Mohammad H. Eslami, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School and the UMass Memorial Health Care, Worcester, Mass
  • ,
  • Michael J. Rohrer, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School and the UMass Memorial Health Care, Worcester, Mass
  • ,
  • Bruce S. Cutler, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School and the UMass Memorial Health Care, Worcester, Mass
    • Corresponding Author InformationReprint requests: Bruce S. Cutler, MD, Division of Vascular Surgery, UMass Memorial Health Care, 55 Lake Avenue North, Worcester, MA 01655.

Received 4 June 2007 ,Accepted 11 November 2007.

References 

  1. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3:104–114
  2. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, Freischlag JA, Ahn SS, Baker JD, et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg. 1992;16:209–217
  3. Boyce B. Physical characteristics of expanded polytetrafluoroethylene grafts. In:  Stanley JC editors. Biological and synthetic vascular prostheses. New York: Grune and Straton; 1982;p. 553–561
  4. Ikada Y. Surface modification of polymers for medical applications. Biomaterials. 1994;15:725–736
  5. Bjorck . Thrombin uptake and inhibition on heparinized polytetrafluoroethylene (PTFE) grafts and native sheep vessels. Thromb Res. 1986;42:605
  6. Ebert CD, Lee ES, Kim SW. The antiplatelet activity of immobilized prostacyclin. J Biomed Mater Res. 1982;16:629–638
  7. Geary RL, Koyama N, Wang TW, Vergel S, Clowes AW. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries (The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation). Circulation. 1995;91:2972–2981
  8. Ito Y, Imanishi Y, Sisido M. In vitro platelet adhesion and in vivo antithrombogenicity of heparinized polyetherurethaneureas. Biomaterials. 1988;9:235–240
  9. Ohshiro T, Kosaki G. Urokinase immobilized on medical polymeric materials: Fundamental and clinical studies. Artific Organs. 1980;4:58–64
  10. Piao AZ, Jacobs HA, Park KD, Kim SW. Heparin immobilization by surface amplification. ASAIO J. 1992;38:M638–M643
  11. Ritter EF, Fata MM, Rudner AM, Klitzman B. Heparin bonding increases patency of long microvascular prostheses. Plast Reconstr Surg. 1998;101:142–146
  12. Senatore F, Bernath F, Meisner K. Clinical study of urokinase-bound fibrocollagenous tubes. J Biomed Mater Res. 1986;20:177–188
  13. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A. 1981;78:2249–2252
  14. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J. 1995;9:946–955
  15. Jackman RW, Beeler DL, VanDeWater L, Rosenberg RD. Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor. Proc Natl Acad Sci U S A. 1986;83:8834–8838
  16. Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J. 1987;6:1891–1897
  17. Wen D, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry (Mosc). 1987;26:4350–4357
  18. Li JM, Singh MJ, Nelson PR, Hendricks GM, Itani M, Rohrer MJ, et al. Immobilization of human thrombomodulin to expanded polytetrafluoroethylene. J Surg Res. 2002;105:200–208
  19. Li JM, Garnette CS, Cahn M, Claytor RB, Rohrer MJ, Dobson JG, et al. Recombinant thrombomodulin inhibits arterial smooth muscle cell proliferation induced by thrombin. J Vasc Surg. 2000;32:804–813
  20. Li JM, Singh MJ, Itani M, Vasiliu C, Hendricks G, Baker SP, et al. Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 2004;39:1074–1083
  21. Verbeke G, Lesaffre E. The linear mixed model: a critical investigation in the context of longitudinal data. In:  Gregoire T editors. Proceedings of the Nantucket Conference on Modeling Longitudinal and Spatially Correlated Data: Methods, Applications, and Future Directions. New York: Springer Verlag; 1997;p. 89–99
  22. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. The SAS system for mixed models. Cary, NC: SAS Institute Inc; 1996;
  23. Bailar JC, Mosteller F. Medical uses of statistics. Boston: The New England Journal of Medicine Books; 1992;
  24. Daniel WW. Applied Nonparametric Statistics. PWS-Kent, Boston: Chapman and Hall; 1990;
  25. Bui TD, Gordon IL, Nguyen T, Fujitani RM, Wilson SE, Conroy RC. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography. Ann Vasc Surg. 2006;20:200–208
  26. Ansel GM, Botti CF, Silver MJ. The use of femoropopliteal stent grafts for critical limb ischemia. Techniques in vascular and interventional radiology. 2005;8:140–145

 Competition of interest: none.

PII: S0741-5214(07)01778-8

doi: 10.1016/j.jvs.2007.11.025

Journal of Vascular Surgery
Volume 47, Issue 3 , Pages 608-615 , March 2008